Advertisement rdharma@digitalinsightresearch.in, Author at Pharmaceutical Business review - Page 64 of 92
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Pfizer gets FDA approval for oncology biosimilar Trazimera

Trazimera has been approved to treat human epidermal growth factor receptor-2 (HER2) overexpressing breast cancer and HER2 overexpressing metastatic gastric or gastroesophageal junction adenocarcinoma. Pfizer Oncology global president